#food and drug agency
The super-virus that causes COVID-19 in Indonesia is taking more and more victims and is estimated to have not yet reached its peak. In the midst of this difficulty is some good news, like a light at the end of the tunnel. The Eijkman Institute of Molecular Biology immediately started the treatment of COVID-19 patients using blood plasma from patients who have been declared healthy. This method can be called plasma recovery. On Monday (20/4/2020), head of the Eijkman Institute of Molecular Biology Amin Subandrio said his agency, with the support of the Food and Drug Agency (Badan POM) and the Health Ministry, was ready to implement the plasma recovery method treatment in the coming weeks. On Tuesday (28/4), Kompas reported, state-owned pharmaceutical company PT Biopharma and Gatot Soebroto Army Hospital joined in this fast-moving innovation.